pH/GSH dual-responsive nanoparticle for auto-amplified tumor therapy of breast cancer
Shengnan Huang,Zhiling Xu,Weiwei Zhi,Yijing Li,Yurong Hu,Fengqin Zhao,Xiali Zhu,Mingsan Miao,Yongyan Jia
DOI: https://doi.org/10.1186/s12951-024-02588-0
IF: 10.2
2024-06-12
Journal of Nanobiotechnology
Abstract:Breast cancer remains a malignancy that poses a serious threat to human health worldwide. Chemotherapy is one of the most widely effective cancer treatments in clinical practice, but it has some drawbacks such as poor targeting, high toxicity, numerous side effects, and susceptibility to drug resistance. For auto-amplified tumor therapy, a nanoparticle designated GDTF is prepared by wrapping gambogic acid (GA)-loaded dendritic porous silica nanoparticles (DPSNs) with a tannic acid (TA)-Fe(III) coating layer. GDTF possesses the properties of near-infrared (NIR)-enhanced and pH/glutathione (GSH) dual-responsive drug release, photothermal conversion, GSH depletion and hydroxyl radical (·OH) production. When GDTF is exposed to NIR laser irradiation, it can effectively inhibit cell proliferation and tumor growth both in vitro and in vivo with limited toxicity. This may be due to the synergistic effect of enhanced tumor accumulation, and elevated reactive oxygen species (ROS) production, GSH depletion, and TrxR activity reduction. This study highlights the enormous potential of auto-amplified tumor therapy.
biotechnology & applied microbiology,nanoscience & nanotechnology